Retaplase plus abciximab improves non-fatal outcomes, but not overall survival in people with diabetes and acute ST-segment elevation myocardial infarction

Victor Serebruany

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Retaplase plus abciximab improves non-fatal outcomes, but not overall survival in people with diabetes and acute ST-segment elevation myocardial infarction'. Together they form a unique fingerprint.

Medicine & Life Sciences